Cancer

An essential nutrient and the gut flora, thought to have separate but important roles in the immune response, join forces.

In this webinar, Pinaki Bose and Fei Chen will discuss how scientists use spatial biology techniques to study the tumor microenvironment.

Cellular immunogenicity and immunotoxicity assays help scientists design, validate, and translate therapeutic research into treatments that weaponize the immune response against cancer.

Explore a cfDNA library preparation workflow that maximizes sensitivity and conversion with low sample inputs.

Biobanks fuel the multiomics-based practice of personalized oncomedicine and cancer biomarker discovery.

A wayward lab chair ended three days of work in a single footfall for Elinne Becket.

A new study finds an unexpected role for hepatocytes in anticancer immunity.

Laboratory hereditary testing takes center stage in this informative guide. 

Yejing Ge explores the behavior of skin-resident stem cells in wound repair, cancer, and aging.

Detection panels that enrich RNA transcripts help scientists achieve sensitive and relevant analyses of cancer-causing gene fusions.

Immune cells form different communities throughout a tumor, potentially disrupting how cancers respond to treatments.

An automated bioprinting and imaging platform allows researchers to examine heterogeneous responses to anticancer drugs within a tumor organoid population.

Lukas Chavez uses multiomic techniques to study how extrachromosomal DNA (ecDNA) contributes to tumor heterogeneity and gene expression changes in medulloblastoma.

Júlia Crispim da Fontoura explains how researchers grow different types of 3D cell cultures.

Superior quality cytokines are crucial for reliable research results and the safe production of cancer cell therapies.

The FOXO1 transcription factor boosts T cells’ memory and reduces dysfunction.

Biochemist Sharon Stack hopes to advance the field of ovarian cancer by exploring the tumor and host-related factors that influence its metastatic process. 

An immune-inhibiting protein that regulates autophagy halts breast cancers from venturing across tissue borders.